The FinLogic News | Insights on Blockchain, Stocks & Futures

PDYN from $2 to $5

Buy Alert sent out in our chatroom at $3 Show me a more beautiful breakout today in any market, I'll wait

$NASDAQ:RGTI breaking out of a bullish flag

NASDAQ:RGTI appears to be breaking out of a bullish flag with ~$14 Price Target (PT). Awaiting confirmation on volume, but 100M shares have traded 2 hours into the trading day, which matches recent daily volume. Long story short... looks like there's going to be a lot of volume today. As I get closer to the PT, I'll set up a trailing stop to help maximize profits/minimize loss. Good luck!

12 NOV - AAPL BUY - BULLISH TRIANGLE

In my previous analysis, during Apple’s retracement period when everyone was panicking, we kept a cool head, and I made an excellent prediction for Apple that hit all the targets I had set. Today, I’m sharing my updated analysis: an ascending bullish triangle on Apple’s 1-day and 1-week charts, with a target set using Fibonacci reversal levels. The Fibonacci retracement zone has already been reached with the August carry trade, but it rebounded quickly. So, if the triangle fails, we might see Apple return to that zone, ready to extend towards the target (green box). Perfect conditions to make some gains from our Apple position.

Here’s What to Expect From DexCom’s Next Earnings Report

Switch the Market flag for targeted data from your country of choice. Open the menu …

Bitcoin price today: dips to $96k in thin trading, tracks 2nd straight weekly fall

-- Bitcoin extended declines on Friday amid soft year-end trading volumes, while investors stayed cautious about the prospect of cryptocurrencies after the Federal...

G7 antitrust watchdogs signal possible action on AI sector competition

G7 nations’ antitrust authorities have signaled they may take “vigorous” enforcement action to protect competition …

Two Teens Arrested for Assault on Former NY Gov. David Paterson

Police have arrested two teens for allegedly assaulting former New York Gov. David Paterson and …

AIRE - AI powered real estate tech. & invest. company

ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment. Float 11.967M Recent news: reAlpha Acquires USRealty Brokerage Solutions For A Purchase Price Of $250,000 In The Form Of In-Kind Services To Be Provided By The Company reAlpha Acquires USRealty and Invests in Unreal Estate to Gain Ability to Expand into 33 U.S. States Breakout Key- Zone above: $1.50 -1.65 Action: If the stock breaks above this area with strong volume, it might signal a continuation of the upward trend. Overall Market Sentiment: It’s always crucial to consider overall market sentiment when making trading decisions. Resistance Points /Zones: $1.20 $1.40 $2.00 -2.20 $3.00 Surpassing these levels could signal a positive trend. Consider taking profits at these stages to realize gains. Trading Strategy: This could potentially be a pump and dump play, so be cautious. Due to its low float, it has the potential to move extremely fast. This could also be a hidden sleeping giant for the long term! Take Profit (TP): Set a target at $4.00 Stop Loss (SL): Set at under $0.50 or with less risk under $0.80 to mitigate potential losses. Chart Analysis: Please refer to the attached chart for detailed analysis of price trends and movements. Trading Advisory: Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities. Disclaimer: This content is for informational purposes only and should not be considered financial advice.

ALXO - Potential Pre - Run-Up into Phase 1b/2 Confernce

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Float: 30.437M Short % of Float: 23.74% 12/12/2024 ET Phase 1b/2 presentation due at December 12, 2024. Phase 1b/2 first patient dosed, October 5, 2021. Drug: Zanidatamab and Evorpacept (ALX148) HER2 Breast cancer and solid tumors Strategy: We may observe a slight pre-run-up leading into the presentation. If your position is in profit by that point, it’s wise to secure gains by taking at least partial profits, as the presentation’s outcome is highly speculative. Key Insights on ALXO: ALXO has a robust pipeline, presenting promising growth potential. Key catalysts are expected by mid-2025, which could significantly impact the company’s valuation. Overall Market Sentiment: It’s always crucial to consider overall market sentiment when making trading decisions. Breakout Zone: $1.80 Resistance Point: $1.95 Surpassing these levels could signal a positive trend. Consider taking profits at these stages to realize gains. Risk/Money Management Take Profit (TP): Set a target at $2.20 Stop Loss (SL): Set at under $1.50 to mitigate potential losses. Chart Analysis: Please refer to the attached chart for detailed analysis of price trends and movements. Trading Advisory: Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities. Disclaimer: This content is for informational purposes only and should not be considered financial advice.

low time frame levels for TSLA

if 445 broken I am expecting the price to go to 435 but if not and breake 450 level it can go back to 46* NASDAQ:TSLA

Symbotic Hypergrowth? $850 Price Target

Overview Symbotic Inc. is an A.I. and robotics automation company based in Wilmington, Massachusetts that is looking to increase the ability for companies to keep up with growing demand. To do this, they utilize artificial intelligence software to maintain records and warehouse organization with the assistance of SKU numbers. Autonomous robots then account for, store, and retrieve items in a fraction of the time that it would take a human being. Symbotic's mission is to increase supply capabilities through the symbiotic relationship of artificial intelligence and robots. Its origins trace back to 2007, before it was known as Symbotic, and the company went public in 2022 ( NASDAQ:SYM ). Call it FOMO, but I think Symbotic Inc. has the potential of becoming a hypergrowth stock. I built my own fundamentals tracker to get a pulse on the tech company's vitals and, while it still is not a profitable company, it looks like it's in the early stages of becoming so. The fundamentals for Symbotic provide me the confidence to invest despite the presence of red flags which led me to performing a deep dive. My price target for Symbotic Inc. is $850 with a projected timeline before 2030. What I Don't Like SYM has lost nearly 60% in value since July 2023 from a high of $64.15 to its current share price of $26.87. If you look up Symbotic Inc. on a search engine then you will also see that there are numerous law firms attempting to build class action lawsuits. The headlines can't help but to sow distrust by utilizing strong statements such as "misleading investors" and "inflated revenue" within their subjects. Within the last few weeks Symbotic had to file a delayed annual report due to self-identified accounting errors within their balance sheets. Also, if you dig through their filings, you will find that Symbotic Inc. was born from a deal with SVF Investment Corp which, according to the filings, was headquartered in the Cayman Islands. I can only assume that the business dealings with SVF Investment Corp were to facilitate equity financing and an expedited public launch for SYM. From my findings, SoftBank Group Corp ( TSE:9984 ) is an investment conglomerate and the parent company to multiple subsidiaries. You guessed it, it is affiliated with SVF Investment Corp which functions as a "blank check company" for SoftBank. In my limited knowledge, this translates as a way for SoftBank to inject a substantial investment into the company that is now known as Symbotic Inc. No matter how savvy they may have been to launch Symbotic Inc., business deals that originate in the Cayman Islands typically raise one's eyebrows. What I Do Like Symbotic Inc. seems to have a pretty solid vision for global expansion and has attracted some significant institutional investors such as SoftBank, Vanguard, BlackRock, and Morgan Stanley to name a few. In fact, according to the NASDAQ site, 282 institutional investors hold 82% of Symbotic Inc.'s Class A Common Stock. Symbotic Inc. was founded by Richard "Rick" Cohen who currently serves as the CEO and is a legacy to the Cohen family who founded C&S Wholesale Grocers. Symbotic's technology is used by C&S Wholesale Grocers which is one of the largest privately held companies in the United States. Symbotic and SoftBank have partnered on a separate venture known as GreenBox which is meant to deliver automated warehouses made possible by Symbotic's hardware and software. According to the company's site, GreenBox is supplying warehouses as a service to consumers. With an increase in online shopping, I believe that Symbotic is both seeing and filling a need in an industry that its founder is very familiar with. I can also envision Symbotic spreading its reach internationally which helps fuel my massive price target. Megacap stocks need to have a global influence and extend across industries, which Symbotic appears to be preparing for. Fundamentals Right now, Symbotic Inc. is in its early stages and is bringing in a negative income which makes it a risky investment. However, the company's total revenue has increased by 200% from 2022-Q4 to 2024-Q4; the gross profit has also increased by 147% in the same timeframe. Symbotic's net income has revealed consistent losses since 2022, but the 2024 annual report had the smallest loss on record at a negative $84.7M which is a 39% improvement from 2022 and a 59% improvement from 2023. No matter which way you cut it, the company is still absorbing annual losses so it will be important to keep an eye on improvements and deficiencies to identify any consistent trends. NASDAQ:SYM has 585,963,959 total outstanding shares according to the 2024 Annual Report published at the beginning of December. This is a far cry from the 106M outstanding shares reported on some financial websites and even here on TradingView. From my findings, around 100M of Symbotic's shares are Class A Common Stocks and the remaining 485M are Class V Common Stocks. My focus is on the market capitalization which is a tool that I like to use when establishing long-term price targets. For Symbotic, which has the potential for global reach and use across multiple industries, I think it's reasonable to achieve a market capitalization of $500B. Price Target With the current number of outstanding shares at a market cap of $500B, this would place Symbotic's share price at $853. This type of growth would turn a $1,000 investment today into $31,710 at the projected target price; a whopping 3,000% return. HOWEVER, a lot has to happen to make this come to fruition. One thing I would like to see, in addition to profitability, is for Symbotic to begin buying back its own stock. It's become my investing philosophy that companies who believe they are undervalued will buyback their shares while companies that believe they are overvalued will issue new shares. Symbotic's total outstanding shares have increased by 5.8% since its annual report at the end of 2022. I think that my philosophy is best tailored to established companies so it is possible that Symbotic could be an exception. Because the company is so new, it may need to issue more shares to generate enough capital to stay afloat while its roots set.